title: Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used.
authors.forename: Johan
authors.initials: J
authors.lastname: van Griensven
authors.forename: Thai
authors.initials: T
authors.lastname: Sopheak
authors.forename: Olivier
authors.initials: O
authors.lastname: Koole
authors.forename: Gert A
authors.initials: GA
authors.lastname: Verpooten
authors.forename: Lutgarde
authors.initials: L
authors.lastname: Lynen
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005919:Glomerular Filtration Rate; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis*; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine